Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro and orlistat work through completely different mechanisms, so taking them at the same time is not straightforwardly ruled out — but it is not straightforwardly recommended either. No licensed UK guidance currently endorses combining these two weight-loss medicines, and a prescriber's review is essential before doing so. Both are prescription-only medicines in their higher-strength forms, which means the decision belongs with a clinician who knows your full medical picture, not with a symptom checker or a forum thread. The sections below walk through what each medicine does, why the combination raises practical questions, and how the process of getting a considered answer actually works.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Orlistat works entirely in the gut. It blocks an enzyme called lipase, which normally breaks down dietary fat so the body can absorb it. Block the enzyme, and roughly a third of the fat you eat passes straight through, unabsorbed. The consequence is that a high-fat meal while taking orlistat can cause oily stools, urgency and discomfort, the medicine's way of making greasy food a less appealing choice. You can read the full NHS guidance on orlistat on the NHS medicines pages.
Mounjaro takes a different route entirely. Tirzepatide activates two hormone receptors, GIP and GLP-1, that are involved in appetite signalling and blood-sugar regulation. The result is a meaningful reduction in hunger, slower gastric emptying, and a tendency to feel full from smaller portions. It does not interact with fat absorption in the gut the way orlistat does. Our Mounjaro overview covers how it works in more detail.
Because the pathways are separate, there is no direct pharmacokinetic clash between the two. But that is not quite the same as saying the combination is fine.
Both orlistat and Mounjaro list gastrointestinal side effects as the most common ones. Orlistat commonly causes loose or oily stools, urgency and flatulence, particularly early in treatment or after a fatty meal. Mounjaro commonly causes nausea, diarrhoea, constipation, indigestion and stomach discomfort, especially in the first few weeks after starting or increasing a dose. Pile one GI-heavy medicine on top of another and the result can be cumulative rather than neutral.
For many people, the tolerable starting dose of Mounjaro (2.5mg) is already a period of adjustment. Adding orlistat's gut effects at the same time could make side effects harder to manage and may affect how well people stick to treatment, which matters because both medicines work best when taken consistently. The question a prescriber weighs is not just "do these medicines interact chemically" but "can this person realistically tolerate both together, and does the combination add enough clinical benefit to justify the burden?" If you want a closer look at exactly how prescribers think through this, our page on taking orlistat with Mounjaro walks through the key considerations in detail.
If you are already wondering about combining weight-loss options, it is also worth looking at Mysimba alongside Mounjaro for a comparison of how prescribers approach different combination scenarios.
A prescriber considering this question would want to know: which medicine you are currently taking, at what dose, and for how long; how you have tolerated it; what your current weight trajectory looks like; whether you have any conditions that affect the gut, kidneys or liver; and what other medicines you take. Orlistat can affect the absorption of fat-soluble vitamins and some oral medicines (including, in some circumstances, hormonal contraceptives) so context matters beyond the headline question.
Mounjaro slows gastric emptying, which can in principle affect the absorption timing of other oral medicines taken alongside it. Orlistat stays in the gut and does not enter the bloodstream significantly, so a direct systemic interaction is unlikely, but the same cannot be said about practical tolerability. The prescriber's job is to hold all of this together and give you an answer that fits your situation, not a generic one. If you are also curious about how Mounjaro interacts with other medicines you take, the page on Mounjaro and metformin together covers a related decision process.
Cost is sometimes part of the picture too. If someone is on orlistat partly because of price and is considering whether Mounjaro might replace rather than supplement it, our weight-loss treatment page sets out what a private consultation covers and what the cost structure looks like.
The practical answer to whether you can take Mounjaro and orlistat at the same time is: possibly, but it requires a prescriber's sign-off, and many prescribers will counsel against it unless there is a specific clinical reason. The more common clinical pathway is to use one medicine, assess response over time, and adjust from there, not to layer two weight-loss treatments simultaneously without evidence that the combination is necessary or safe for you individually.
If you are currently on orlistat and wondering whether Mounjaro might be an option, the eligibility criteria for Mounjaro are a useful starting point. Adults with a BMI of 30 or above, or 27 or above with a weight-related condition such as high blood pressure or type 2 diabetes, may qualify, but BMI alone does not determine suitability, and a full clinical assessment is needed. The general guide to whether Mounjaro is right for you also covers what the assessment considers.
One practical note: if you are already on Mounjaro and keep your pen in the fridge door next to everyday items, it is a useful reminder to stay consistent with timing, but it also highlights why telling your prescriber about every other medicine you take (including something as over-the-counter as orlistat in its lower dose) is worth doing at your next review rather than waiting.
The NHS medicines information on tirzepatide lists the known cautions and side effects clearly, and a prescriber at nume will review your full picture before making any recommendation. Speak to our prescribers if you are weighing up your options, the consultation is free and reviewed the same day by a GPhC-registered clinician, not a chatbot.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.